http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID695337_PMID23017888

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163316872_AID695337_PMID23017888_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163313475_AID695337_PMID23017888_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163320357_AID695337_PMID23017888_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103345901_AID695337_PMID23017888_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103230651_AID695337_PMID23017888_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163323753_AID695337_PMID23017888_VALUE6
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08183
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Inhibition of human P-gp overexpressed in doxorubicin resistant A2780adr cells at 10 uM preincubated for 30 mins prior to calcein AM addition measured every 60 secs up to 90 mins by calcein AM accumulation assay
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163323753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163320357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163316872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103345901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163313475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103230651
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID695337

Total number of triples: 17.